EcoDrugPlus

Solute Carrier Family 6 Member 1

Ensembl ID : ENSBMSG00010009806
Gene Symbol: SLC6A1
1 Cross references
279 Possible Orthologues:

Solute Carrier Family 6 Member 2

Ensembl ID : ENSBMSG00010016702
Gene Symbol: SLC6A2
1 Cross references
204 Possible Orthologues:

Solute Carrier Family 6 Member 3

Ensembl ID : ENSBMSG00010014310
Gene Symbol: SLC6A3
1 Cross references
167 Possible Orthologues:

Solute Carrier Family 6 Member 4

Ensembl ID : ENSBMSG00010016971
Gene Symbol: SLC6A4
1 Cross references
205 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSBMSG00010011996
Gene Symbol: SLC6A9
1 Cross references
206 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSBMSG00010012631
Gene Symbol: SLC9A3
1 Cross references
238 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSBMSG00010002019
Gene Symbol: SSTR1
1 Cross references
160 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSBMSG00010016798
Gene Symbol: SSTR2
1 Cross references
264 Possible Orthologues:

Somatostatin Receptor 3

Ensembl ID : ENSBMSG00010008930
Gene Symbol: SSTR3
1 Cross references
251 Possible Orthologues:

Somatostatin Receptor 4

Ensembl ID : ENSBMSG00010013828
Gene Symbol: SSTR4
1 Cross references
102 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSBMSG00010019119
Gene Symbol: SSTR5
1 Cross references
257 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSBMSG00010017078
Gene Symbol: SPHK2
1 Cross references
209 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).